Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 243 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-09-01 202830
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-09-28 2024-03-15 205480
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-01-12 206579
APO-OXYCODONE CR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-06 208382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-06 2024-03-15 209286
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-04-19 209298
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-01-12 209339
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2023-12-15 209372
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-17 2024-02-02 210689
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-24 2024-02-09 211484
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-26 212362
APO-DARIFENACIN 15MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-01 2024-02-02 212368
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-05 212392
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-08 2024-01-19 212969

Showing 2941 to 2960 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-DICLOFENAC OPHTHALMIC 0.1% SOLUTION Discontinued 2018-09-07 2019-02-13 60426
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-CICLESONIDE 50MCG SPRAY, METERED DOSE Discontinued 2018-12-20 2018-12-21 70250
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 25MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1096
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-NITRAZEPAM 5MG TABLET Discontinued 2017-03-13 2018-12-07 1110
APO-NITRAZEPAM 10MG TABLET Discontinued 2017-03-13 2018-12-07 1117

Showing 101 to 120 of 356